To minimize management risk in gene and cell therapy packaging, organizations must implement a data-driven cold chain packaging validation strategy. This involves verifying container-closure integrity (CCI) after exposure to extreme temperatures, testing material robustness to prevent brittle failure, and ensuring label traceability remains intact despite a steep temperature gradient. Continue reading